pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
psilocybin · news · pharmadog
← back to psilocybin
News mentioning psilocybin
31
stories
16h
STAT+: How a Trump loyalist got the FDA nomination
stat
23h
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
stat
1d
Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analysts
biospace
1d
STAT+: Experts scrutinize Huidagene’s disclosures after patient death
stat
1d
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
stat
1d
STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
stat
1d
STAT+: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions
stat
2d
STAT+: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firm
stat
2d
STAT+: Real-world psilocybin data suggest need for close monitoring
stat
2d
Rebounding biotech funds expected to spur CDMO growth within year
biospace
7d
Nascent US psychedelic therapy opportunity attracts overseas manufacturers
biospace
8d
Definium’s LSD asset beats analyst expectations in Phase 3 anxiety readout
biospace
10d
All eyes on psychedelic drugmakers as Definium, Compass near major catalysts
biospace
11d
Psychedelics on the cusp of market breakthrough as clinical, policy support grow
biospace
14d
Chutes & Ladders—BioNTech brings in Sobi CEO
fiercebiotech
16d
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
21d
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
27d
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
biospace
Jul 20, 26
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics
biospace
Jul 18, 26
‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics
fiercebiotech
Jul 16, 26
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
biopharma dive
Jul 16, 26
Lilly makes up to $3.8B psychedelics play in AtaiBeckley takeover
biospace
Jul 16, 26
J&J sees Spravato sales surge as psychedelic competitors loom
biospace
Jul 7, 26
Compass Pathways touts durability data for psilocybin drug in depression ahead of year-end filing
endpoints
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
May 6, 26
Opinion: Trump’s executive order on psychedelics is the right move. But is my field ready for it?
stat
May 1, 26
Opinion: The psychedelic revolution is leaving behind people of color
stat
Apr 30, 26
Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier
stat
Apr 27, 26
What’s the true risk for eating disorders with GLP-1s?
stat
Apr 24, 26
STAT+: FDA to speed up review of three psychedelics as mental health treatments
stat
← prev
page 1 of 2
next →
